4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-ethoxyphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-ethoxyphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-ethoxyphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
Compound ID: | L310-3216 |
Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-ethoxyphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
Molecular Weight: | 498.56 |
Molecular Formula: | C24 H26 N4 O6 S |
Smiles: | CCOc1ccc(cc1)NS(c1cc2c(cc1C)N(Cc1nc(C3CCC3)on1)C(CO2)=O)(=O)=O |
Stereo: | ACHIRAL |
logP: | 3.592 |
logD: | 3.5844 |
logSw: | -3.822 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 105.033 |
InChI Key: | SVLMDYKNZOCKIS-UHFFFAOYSA-N |